Prior to his resignation, Gottlieb said that he planned for the agency to hold a public hearing, “in the near future”, to gather feedback from stakeholders regarding their use of CBD products as well as hear out any safety concerns. “We’ll use this meeting to gather additional input relevant to the lawful pathways by which products containing cannabis or cannabis-derived compounds can be marketed, and how we can make these legal pathways more predictable and efficient,” he said in a statement.
No comments:
Post a Comment